Bayer Baycol-related layoffs
Executive Summary
Bayer will cut pharmaceutical group by 1,250 employees following withdrawal of the cholesterol-reducing drug Baycol (cerivastatin), CFO Werner Wenning says Oct. 2. The cuts are on top of a previously announced global headcount reduction by 4,000 positions (not all of which are in pharma)